These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26475416)

  • 1. Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System.
    Zhou L; Mo H; Miao J; Zhou D; Tan RJ; Hou FF; Liu Y
    Am J Pathol; 2015 Dec; 185(12):3211-23. PubMed ID: 26475416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-catenin regulates blood pressure and kidney injury in rats.
    Xiao L; Xu B; Zhou L; Tan RJ; Zhou D; Fu H; Li A; Hou FF; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1313-1322. PubMed ID: 30710617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.
    Zhou L; Li Y; Zhou D; Tan RJ; Liu Y
    J Am Soc Nephrol; 2013 Apr; 24(5):771-85. PubMed ID: 23559584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signaling and renin-angiotensin system in chronic kidney disease.
    Zhou L; Liu Y
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):100-6. PubMed ID: 26808707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes.
    Takenaka T; Kobori H; Miyazaki T; Suzuki H; Nishiyama A; Ishii N; Yamashita M; Hayashi M
    Acta Physiol (Oxf); 2019 Feb; 225(2):e13190. PubMed ID: 30251773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Wnt/β-catenin/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats.
    Younis NN; Mohamed HE; Shaheen MA; Abdelghafour AM; Hammad SK
    Biochem Pharmacol; 2021 Mar; 185():114426. PubMed ID: 33482150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho Ameliorates Medullary Fibrosis and Pressure Natriuresis in Hypertensive Rat Kidneys.
    Takenaka T; Inoue T; Miyazaki T; Kobori H; Nishiyama A; Ishii N; Hayashi M; Suzuki H
    Hypertension; 2018 Nov; 72(5):1151-1159. PubMed ID: 30354813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation effect of WNT-RAS signaling in hypothalamic paraventricular nucleus on renal fibrosis.
    Zhou G; Li J; Zeng T; Yang P; Li A
    J Nephrol; 2020 Apr; 33(2):289-297. PubMed ID: 31392659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling.
    Zhou L; Li Y; Hao S; Zhou D; Tan RJ; Nie J; Hou FF; Kahn M; Liu Y
    J Am Soc Nephrol; 2015 Jan; 26(1):107-20. PubMed ID: 25012166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho suppresses the renin-angiotensin system in adriamycin nephropathy.
    Takenaka T; Inoue T; Miyazaki T; Kobori H; Nishiyama A; Ishii N; Hayashi M; Suzuki H
    Nephrol Dial Transplant; 2017 May; 32(5):791-800. PubMed ID: 27798196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
    Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
    Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY
    Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome.
    Zhao Y; Wang C; Hong X; Miao J; Liao Y; Hou FF; Zhou L; Liu Y
    Kidney Int; 2019 Apr; 95(4):815-829. PubMed ID: 30770217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
    Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
    BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
    Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
    Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.
    Satoh M; Nagasu H; Morita Y; Yamaguchi TP; Kanwar YS; Kashihara N
    Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1641-51. PubMed ID: 23034937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction.
    Miao J; Liu J; Niu J; Zhang Y; Shen W; Luo C; Liu Y; Li C; Li H; Yang P; Liu Y; Hou FF; Zhou L
    Aging Cell; 2019 Oct; 18(5):e13004. PubMed ID: 31318148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.
    Wang M; Chen DQ; Chen L; Cao G; Zhao H; Liu D; Vaziri ND; Guo Y; Zhao YY
    Br J Pharmacol; 2018 Jul; 175(13):2689-2708. PubMed ID: 29679507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.